Table 2.
Treatment-emergent adverse events reported by ≥ 5% of treated patients by preferred term and study drug relationship: data are number of patients with rates in brackets (N = 95)
| All Causalities | Treatment Related | |
| Patients with ≥ 1 adverse event | 75 (78.9) | 55 (57.9) |
| Pyrexia | 25 (26.3) | 11 (11.6) |
| Asthenia | 13 (13.7) | 9 (9.5) |
| Dyspnea | 11 (11.6) | 1 (1.1) |
| Neutropenia | 10 (10.5) | 10 (10.5) |
| Vomiting | 10 (10.5) | 9 (9.5) |
| Diarrhea | 10 (10.5) | 9 (9.5) |
| Anemia | 10 (10.5) | 8 (8.4) |
| Nausea | 9 (9.5) | 9 (9.5) |
| Fatigue | 9 (9.5) | 8 (8.4) |
| Cough | 8 (8.4) | 3 (3.2) |
| Anorexia | 6 (6.3) | 1 (1.1) |
| Leucopenia | 5 (5.3) | 5 (5.3) |
| Mucosal inflammation | 5 (5.3) | 5 (5.3) |
| Thrombocytopenia | 5 (5.3) | 5 (5.3) |
| Rash | 5 (5.3) | 4 (4.2) |
| Chest pain | 5 (5.3) | 1 (1.1) |
| Peripheral Edema | 5 (5.3) | 1 (1.1) |